NCT00345735View on ClinicalTrials.gov

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

CancerPain

Interventions

DRUG

Fentanyl

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Nycomed

INDUSTRY

NCT00345735 - Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM) | Biotech Hunter | Biotech Hunter